Serina Therapeutics (SER) Enterprise Value (2017 - 2025)
Serina Therapeutics (SER) has disclosed Enterprise Value for 9 consecutive years, with -$3.1 million as the latest value for Q4 2025.
- Quarterly Enterprise Value rose 19.68% to -$3.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.1 million through Dec 2025, up 19.68% year-over-year, with the annual reading at -$3.1 million for FY2025, 19.68% up from the prior year.
- Enterprise Value hit -$3.1 million in Q4 2025 for Serina Therapeutics, up from -$8.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of $28.8 million in Q4 2023 to a low of -$8.8 million in Q3 2025.
- Historically, Enterprise Value has averaged -$1.1 million across 5 years, with a median of -$784500.0 in 2021.
- Biggest five-year swings in Enterprise Value: soared 4194.59% in 2023 and later plummeted 2125.06% in 2024.
- Year by year, Enterprise Value stood at -$627000.0 in 2021, then dropped by 12.12% to -$703000.0 in 2022, then skyrocketed by 4194.59% to $28.8 million in 2023, then crashed by 113.22% to -$3.8 million in 2024, then grew by 19.68% to -$3.1 million in 2025.
- Business Quant data shows Enterprise Value for SER at -$3.1 million in Q4 2025, -$8.8 million in Q3 2025, and -$6.2 million in Q2 2025.